Tibet Weixinkang Medicine Co., Ltd. (603676) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tibet Weixinkang Medicine Co., Ltd.

Why is Tibet Weixinkang Medicine Co., Ltd. ?

Negative results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY 216.79 MM
ROCE(HY) Lowest at 14.76%
INVENTORY TURNOVER RATIO(HY) Lowest at 12.01 times

With ROE of 17.06%, it has a fair valuation with a 3.39 Price to Book Value

Over the past year, while the stock has generated a return of 12.40%, its profits have risen by 11.5% ; the PEG ratio of the company is 1.7
At the current price, the company has a high dividend yield of 2.9

Underperformed the market in the last 1 year

The stock has generated a return of 12.40% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tibet Weixinkang Medicine Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Tibet Weixinkang Medicine Co., Ltd.

-12.29%

0.64

41.34%

China Shanghai Composite

23.91%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.83%

EBIT Growth (5y)

33.10%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.71

Sales to Capital Employed (avg)

0.84

Tax Ratio

10.80%

Dividend Payout Ratio

60.71%

Pledged Shares

Institutional Holding

ROCE (avg)

32.01%

ROE (avg)

12.94%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.46

EV to EBIT

12.92

EV to EBITDA

10.88

EV to Capital Employed

5.51

EV to Sales

2.40

PEG Ratio

Dividend Yield

3.75%

ROCE (Latest)

42.67%

ROE (Latest)

13.14%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.95% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 7.05 times

NET SALES(Q)

Highest at CNY 318.03 MM

-19What is not working for the Company

INTEREST(HY)

At CNY 0.16 MM has Grown at 89.34%

NET PROFIT(9M)

At CNY 116.22 MM has Grown at -30.57%

OPERATING CASH FLOW(Y)

Lowest at CNY 243.1 MM

NET SALES(9M)

At CNY 855.29 MM has Grown at -10.23%

ROCE(HY)

Lowest at 14.38%

INVENTORY TURNOVER RATIO(HY)

Lowest at 9.24 times

Here's what is working for Tibet Weixinkang Medicine Co., Ltd.

Net Sales

Highest at CNY 318.03 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Debtors Turnover Ratio

Highest at 7.05 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -4.95% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tibet Weixinkang Medicine Co., Ltd.

Interest

At CNY 0.16 MM has Grown at 89.34%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 116.22 MM has Grown at -30.57%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 9.24 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Cash Flow

Lowest at CNY 243.1 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)